Biotechnology
633 companies in this industry
Insider Buys (30d)
92
$91.62M
Insider Sells (30d)
1767
$771.17M
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$121.44BREGNRegeneron Pharmaceuticals, Inc.
$77.57BARGXargenx SE
$45.82BALNYAlnylam Pharmaceuticals, Inc.
$42.07BINSMInsmed Incorporated
$30.07BBNTXBioNTech SE
$24.56BUTHRUnited Therapeutics Corporation
$21.50BINCYIncyte Corporation
$20.10BRVMDRevolution Medicines, Inc.
$20.10BMRNAModerna, Inc.
$19.96BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026↗ | DYN | Dyne Therapeutics, Inc. | Kersten Dirk | director | Sell | 129,672 | $19.52 | $2.53M |
| Mar 13, 2026↗ | PHGE | BiomX Inc. | Yeganeh Reuven | director, 10 percent owner: | Sell | 370,000 | $5.00 | $1.85M |
| Mar 13, 2026↗ | VRTX | Vertex Pharmaceuticals Incorporated | McKechnie Duncan | officer: EVP, Chief Commercial Officer | Sell | 2,633 | $498.42 | $1.31M |
| Mar 12, 2026↗ | IMNM | Immunome, Inc. | BIENAIME JEAN JACQUES | director | Buy | 2,000 | $21.84 | $43.7K |
| Mar 12, 2026↗ | BMRN | BioMarin Pharmaceutical Inc. | Guyer Charles Greg | officer: EVP, Chief Technical Officer | Sell | 16,486 | $60.46 | $996.7K |
| Mar 12, 2026↗ | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | director | Sell | 8,671 | $72.00 | $624.3K |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | Walker Paul Edward | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | Florence Anthony A. Jr. | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | Yang Rick | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | SANDELL SCOTT D | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | New Enterprise Associates 17, L.P. | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | Chang Carmen | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | BASKETT FOREST | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | Mathers Edward T | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | KRRO | Korro Bio, Inc. | Makhzoumi Mohamad | 10 percent owner | Buy | 207,100 | $11.11 | $2.30M |
| Mar 12, 2026↗ | ALEC | Alector, Inc. | Wong-Sarad Grace | officer: Principal Accounting Officer | Sell | 1,000 | $2.65 | $2.6K |
| Mar 12, 2026↗ | PTCT | PTC Therapeutics, Inc. | Okey Stephanie | director | Sell | 14,000 | $70.00 | $980.0K |
| Mar 12, 2026↗ | STOK | Stoke Therapeutics, Inc. | TZIANABOS ARTHUR | director, officer: Interim Executive Chair | Sell | 4,355 | $40.00 | $174.2K |
| Mar 12, 2026↗ | STOK | Stoke Therapeutics, Inc. | Krainer Adrian R. | director | Sell | 33,243 | $39.74 | $1.32M |
| Mar 12, 2026↗ | MAZE | Maze Therapeutics, Inc. | Bernstein Harold | officer: President, R&D & CMO | Sell | 30,000 | $50.45 | $1.51M |